The cardinal role of the liver in protein and amino acid metabolism has been well established. Consequently, studies of amino acid metabolism occupy a natural and fundamental place in an investigation of metabolic aberrations in hepatic disease. In 1913, Van advantage since this serves as a "label" in the interpretation of the metabolic fate of the administered methionine.
The cardinal role of the liver in protein and amino acid metabolism has been well established. Consequently, studies of amino acid metabolism occupy a natural and fundamental place in an investigation of metabolic aberrations in hepatic disease. In 1913, Van Slyke and Meyer (1) demonstrated that certain amino acids when injected intravenously are rapidly removed from the circulation in the normal animal. They also demonstrated that a considerable capacity for temporary storage of amino acids existed in certain tissues, notably liver and muscle. Tolerance to various individual amino acids has been studied in connection with hepatic function. Thus Jastrowitz (2) in 1908 reported a greater urinary content of glycine in patients with liver damage than in normals following oral ingestion of glycine. A tolerance test to orally administered tyrosine was proposed by Bernhart and Schneider (3) as an aid to the diagnosis of hepatic disease. Similar procedures with single and multiple amino acid preparations have been studied by other investigators (4, 5) . The recent development of specific and sensitive microbiologic procedures for the assay of amino acids (6) makes possible the further study of this problem.
By virtue of its prominent role in liver physiology, in the work here reported methionine was selected for a study of amino acid metabolism in normal and hepatopathic individuals. The presence of sulfur in the molecule confers an additional advantage since this serves as a "label" in the interpretation of the metabolic fate of the administered methionine.
In the present study a standard dose of DLmethionine was administered intravenously. Observations were then made on the rate of disappearance of the amino acid from the plasma together with a comparison of the excretion of free methionine and sulfate sulfur before and after the substance was given. Since the racemic DLmethionine was used, it was of interest to follow the metabolism of both isomers. This was made possible by the separate analysis of samples by two micro-organisms, one utilizing only the Lisomer, the other, both D-and L-isomers.
METHODS
All patients (veteran and naval personnel) received a standard high protein, high carbohydrate intake over a two-day period preceding the test, during which time all medication was discontinued. They received no food from 8:00 p.m. the preceding night until after the 180-minute blood and urine samples had been obtained. Methionine determinations were made on deproteinized filtrates of plasma obtained from heparinized blood. After removal of a blood sample for determinations of the fasting methionine level, 50 cc. of a 3 per cent DLmethionine solution were injected over a five-minute period. Blood samples were then drawn at 15, 30, 60, 120, and 180 minutes after the injection. Urine samples corresponding to a two-hour period prior to the administration of the test dose of methionine as well as to the subsequent three-hour period were collected and assayed for methionine and, in some cases, sulfate sulfur (both free and total), and total amino nitrogen. This latter constituent will be discussed in a later communication. In several instances, methionine excretion during various periods up to 48 hours after the test dose had been given was measured.
Methionine was determined microbiologically using as test organisms Leuconostoc mesenteroides, P-60, for the assay of L-methionine and Lactobacillus fermenti, 36, for assay of DL-methionine. Apparent D-methionine concentrations were obtained by difference. All other analytical details were as described in previous publications from this laboratory (7, 8) . Standard chemical methods were used for the sulfur and amino acid determinations (9, 10) .
RESULTS
The data here presented represent observations over a 15-month period on normal men and in men with acute, chronic, convalescent, and healed (inactive) liver disease.
Fasting methionine values
The plasma fasting L-methionine levels varied over a considerable range, from 0.22 to 1.48 mg. Figure 1 also details the average hourly excretion of DL-and L-methionine as well as sulfate sulfur, total and ethereal, measured for the twohour period preceding the methionine injection and during the subsequent three hours. Negligible quantities of L-methionine were excreted at any time. After injection, a maximum of only 3.36 mg. per hour, with an average of 1.12 ± .22 mg. per hour, was found. This indicates that even though the plasma L-methionine level was raised as much as five times the normal fasting level, the maximal rate of renal tubular reabsorption was not reached.
The curve illustrating the average D-methionine levels at intervals after injection of the test amino acid indicates that although the peak values are higher, those obtained at 180 minutes tend to be lower than the comparable L values. Thus a higher rate of disappearance for the D-isomer was usually observed. Inspection of the data on rates and extent of excretion of the D-isomer shows that a very considerable quantity is excreted during the initial three hours and this fact probably accounts in large part for the more rapid removal of this isomer from the plasma. However, so far no consistent pattern for the D-isomer either in rates of disappearance from the plasma or excretion could be detected. Hence, only the L form has been considered in evaluation of metabolic abnormalities in hepatic disease.
Urinary sulfate sulfur excretion during the two hours preceding and the three hours following methionine administration has been utilized as an index of the catabolism of endogenous, and exogenous-plus-endogenous sulfur-containing amino acids, respectively. In an initial group of six normal individuals an average pre-methionine rate of 20.3 mg. per hour was obtained, rising to a rate of 28.0 mg. per hour during the three-hour postmethionine period. Since the sulfur content of the 1500 mg. of methionine administered is 322 mg., it would seem that little of the methionine is catabolized during the initial three-hour period.
Observations in liver disease
It was anticipated that an acutely damaged liver could not as readily utilize administered methionine as the normal organ. The observations to follow support this hypothesis.
(a) Acute Hepatitis. Initial values from 14 patients in the pre-convalescent phase of the disease are included in Figure 3 . It will be noted that the average rate of disappearance of methionine from the plasma in these patients is slower than that for the normals. Ten of these patients had rates ranging from 0. Figure  6 are too few for significance. In Figure 7 are shown a series of pre-and post-methionine urinary sulfate values obtained in a group of patients with chronic liver damage. It temperature was about 3 per cent, and that a 50-cc. syringe was the largest syringe with which one could conveniently work. That this dose proved to be an amount which answered many of our questions, has been a source of gratification.
A few patients have received larger dosages-up to 4.5 grams (150 cc. of a 3 per cent solution) given under the same conditions as those previously described for the smaller amount. The data so obtained indicate that the initial 15-minute values for D-and L-methionine are roughly proportional to the dose; that the disappearance from the plasma of L-methionine follows the same pattern as in the case of the smaller amount; that there is not a significant increase in urinary L-methionine, but that the urinary D-methionine content is roughly proportional to the amount administered (Figures 8a and 8b) The interpretation of the data obtained on plasma and urinary D-methionine is difficult. It is apparent that rapid and considerable renal excretion occurs in all instances. Such data as are available on urinary methionine in patients who received the 4.5 gram dose of DL-methionine, suggest that a mathematical relationship does exist between the size of the dose of the D-isomer and the urinary content of this material, as contrasted to the natural isomer. Whether biological tubular reabsorption exists is still to be determined. In any event, it appears that the rate of disappearance from the plasma, while, on the average, more rapid than that of the natural isomer, cannot be accounted for on the basis of renal excretion alone, nor can it be accounted for on the basis of total catabolism of the methionine molecule. Hence, anabolism of D-methionine must occur. Whether such metabolism initially requires deamination followed by transamination to the L-isomer is unknown to us at the present time. The presence of a specific enzyme (D-amino acid oxidase) in liver and kidney which initiates such a reaction is well known. Quantitation of keto acid production and of other metabolites, now in progress, may help to throw further light on this problem.
Fasting plasma methionine
An additional factor which deserves emphasis in regard to L-methionine is the high fasting level noted in a few patients with acute hepatitis and during the acute phase of chronic liver damage, e.g., Patient-SMI ( Figure 3 ). As the disease subsides, the elevated level returns to normal well before a normal rate of utilization is achieved. The analogy to the behavior of blood dextrose in diabetes is obvious. Work now in progress indicates that very high fasting plasma L-methionine levels in cirrhotics may be found for several days after the discontinuance of oral methionine.
L-methionine metabolism
The evidence in support of the interpretation of the rate of fall during the 30 to 180-minute period is also worthy of further discussion, as such an interpretation is still to be proved. That the rapid fall during the 15 to 30-minute period is largely referable to diffusion, is well evidenced by the plasma-interstitial (edema) fluid values obtained in patient HAN (Figure 2 ). It is also apparent from the same data that once this initial diffusion has occurred, equilibrium is maintained between these two phases of body fluid. As already noted no phase of the L-methionine plasma curve is referable to urinary excretion and hence only two interpretations of the 30 to 180-minute fall appear to be possible, viz., metabolism or intracellular storage. It would appear unlikely that cellular storage of methionine, as such, would be influenced significantly by impaired liver function and thus only one -interpretation remains, viz., utilization (anabolism or catabolism).
Because of the fortuitous presence of sulfur in the methionine molecule, and the mandatory excretion of this sulfur as urinary sulfate when the amino acid is metabolized, one can speak with more assurance of catabolism than of anabolism. From the urinary sulfate data which we have so far obtained, one can say that no significant catabolism of the infused methionine occurs over the threehour post-infusion period, with a single exception (DRE, Figure 7 ). That this exception occurred in a man who died of hepatic insufficiency a few weeks later is probably of considerable importance. This man, to our initial discomfiture, had a normal disappearance rate. In retrospect, we believe that this finding was referable to two factors-the excessive rate of catabolism, and the presence of a huge amount of ascites at the time the test was done. Since the majority of cirrhotics with ascites, but without evidence of excessive catabolism, have had abnormally slow rates, it is probable that the catabolic factor was of more importance in the production of a "normal" rate of disappearance than was the increased interstitial fluid volume.
"False normal" rates of disappearance of the L-isomer have also been noted in a few instances in men who have had abnormally high fasting levels. It may be that one should not attempt to evaluate the utilization rate until the fasting level has returned to normal.
One further word concerning anabolism-catabolism: the small amount of urinary sulfate data which have so far accumulated in normal individuals suggests that little of the administered methionine is catabolized during the first three hours. This could be construed as an anabolic effect. Nitrogen-sulfate ratio determinations now in progress should support or refute this impression. A number of the acute and chronic liver patients have excreted less urinary sulfate after the methionine than in the basal, pre-methionine period. It is our present feeling that this serves as a. significant index of anabolic effect. Confirmation of this impression, and of other of our present interpretations of the data presented, await the accumulation of further pertinent information in the patients here presented, and in others currently under study.
SUMMARY AND CONCLUSIONS 1. Normal human subjects remove intravenously administered methionine from the plasma at a predictable rate.
2. This rate of removal is impaired in many individuals with liver damage.
3. On the basis of the evidence presented, it seems probable that the rate of removal is synonymous with the rate of utilization (anabolism and/ or catabolism).
4. Urinary sulfate may serve as an anabolic/ catabolic index.
5. Under all conditions studied, the urinary excretion of L-methionine is negligible, while that of D-methionine is considerable.
